FREE TOOL · LIVE DATA

RDHL DCF Calculator

Run your own discounted cash flow valuation for RedHill Biopharma Ltd.. The calculator is pre-filled with real data — $-0.0B free cash flow (FY2025) and the live share price — so you only adjust the assumptions.

SEARCH STOCK

Search to auto-fill real company data

COMPANY DATA

Annual, in billions
$B
In billions
B
Per share
$

YOUR ASSUMPTIONS

Projected
%
Required return
%
yrs
Perpetuity
%

YOUR DCF RESULT

CALCULATED FAIR VALUE

$-Infinity

NaN% FAIR VALUE

MARKET

$0.42

YOUR DCF

$-Infinity

MARGIN

$Infinity

VALUE BREAKDOWN

PV of Projected Cash Flows$-0.1B
PV of Terminal Value
$-0.1B58% of total
Total Enterprise Value$-0.2B
÷ Shares Outstanding0B
Fair Value Per Share$-Infinity

SENSITIVITY CHECK

Try adjusting growth rate by ±2% and discount rate by ±1% to see how sensitive your fair value is to assumptions.

COMPARE WITH FPI FAIR VALUE

Your DCF reflects your assumptions. As an independent reference, here is Fair Price Index's daily blended fair value for RedHill Biopharma Ltd. — DCF (50%), relative valuation (30%), and analyst consensus (20%):

RDHL · FPI MODELLIVE DATA · UPDATED DAILY
See the full RDHL valuation breakdown →

Frequently Asked Questions

What is RDHL's free cash flow?

RedHill Biopharma Ltd. generated $-0.0 billion of free cash flow in fiscal year 2025. That figure is pre-filled in the calculator above and refreshed daily.

How do I calculate RDHL's fair value with a DCF?

Project RedHill Biopharma Ltd.'s free cash flow forward at your assumed growth rate, discount each year back at your required return (WACC), add a terminal value, and divide by shares outstanding. The calculator above does all of this instantly as you adjust the assumptions.

What growth rate should I use for RDHL?

Anchor on history and sector reality: look at RedHill Biopharma Ltd.'s revenue and cash flow growth over the past five to ten years, then ask what is sustainable going forward. Testing a conservative and an optimistic scenario matters more than any single number.

Is RDHL undervalued right now?

That depends on the assumptions you feed the model — that is the point of running your own DCF. For an independent reference, Fair Price Index publishes a daily fair value for RedHill Biopharma Ltd. blending DCF, relative valuation, and analyst consensus.

GET ALERTS

Track RDHL's fair value daily

Download Fair Price Index and get notified when RedHill Biopharma Ltd.'s valuation shifts.

Download on the App StoreGet it on Google Play

Trusted by 500+ investors · Free tier available · PRO $2.99/month

RELATED

This calculator is for educational purposes only and does not constitute investment advice. Pre-filled figures come from the latest reported financials and may differ from other sources. Always verify against the company's filings.

FROM BULIOS

Most read on Bulios this week

Fair Price Index is built by Bulios, the investing platform with more than 200,000 investors in six languages. These are the three articles its investors read most over the past seven days.

All articles on Bulios→